- Book
- July 2018
- 257 Pages
- Report
- December 2025
- 26 Pages
Brazil
From €995EUR$1,201USD£894GBP
- Report
- December 2025
- 20 Pages
Algeria
From €995EUR$1,201USD£894GBP
- Report
- November 2025
- 25 Pages
Philippines
From €995EUR$1,201USD£894GBP
- Report
- November 2025
- 19 Pages
Tunisia
From €995EUR$1,201USD£894GBP
- Report
- November 2025
- 125 Pages
New Zealand
From €2675EUR$3,229USD£2,402GBP
- Report
- November 2025
- 28 Pages
New Zealand
From €995EUR$1,201USD£894GBP
- Report
- November 2025
- 25 Pages
Nigeria
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 23 Pages
Singapore
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 22 Pages
Kenya
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 23 Pages
Ireland
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 25 Pages
Spain
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 25 Pages
Italy
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 54 Pages
Myanmar
From €2150EUR$2,595USD£1,931GBP
- Report
- October 2025
- 26 Pages
South Africa
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 22 Pages
North Macedonia
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 112 Pages
Thailand
From €2675EUR$3,229USD£2,402GBP
- Report
- October 2025
- 26 Pages
Thailand
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 24 Pages
Saudi Arabia
From €995EUR$1,201USD£894GBP
- Report
- October 2025
- 25 Pages
France
From €995EUR$1,201USD£894GBP

The Antihistamine market is a segment of the Over the Counter (OTC) Drugs industry. Antihistamines are used to treat allergies, hay fever, and other conditions caused by an overactive immune system. These drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. They are typically taken orally, but some can be applied topically. Common active ingredients in antihistamines include diphenhydramine, loratadine, and cetirizine. Antihistamines are generally considered safe and effective, but they can cause drowsiness and other side effects.
The Antihistamine market is highly competitive, with many large pharmaceutical companies offering a wide range of products. Some of the major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Novartis, Sanofi, Bayer, and Merck. Show Less Read more